5 results
8-K
EX-99.1
SAVA
Cassava Sciences Inc
16 Aug 18
Pain Therapeutics Announces $11.3 Million Registered Direct Offering Priced At-the-Market
7:00am
, General Corporate Purpose –
AUSTIN, Texas, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company
S-1/A
EX-10.6
SAVA
Cassava Sciences Inc
11 May 00
IPO registration (amended)
12:00am
be used by the Company for any corporate purpose, and the
Company shall not be obligated to segregate such payroll deductions.
18. Reports
- Prev
- 1
- Next